N@N

TomoTherapy Announces Radiation Therapy Supply Agreement With MedAssets

_{//health-fitness.news-articles.net/content/2010/ .. ion-therapy-supply-agreement-with-medassets.html}
^{Published in Health and Fitness on Wednesday, June 9th 2010 at 6:10 GMT by Market Wire}  

MADISON, WI--(Marketwire - June 9, 2010) - [ TomoTherapy Incorporated ] (NASDAQ: [ TOMO ]), maker of advanced radiation therapy solutions for cancer care, announced today that it has signed an equipment supply group purchasing agreement with [ MedAssets ]. Through the agreement, customers of MedAssets' group purchasing organization (GPO) will gain access to the TomoTherapy^® technology through an expanded radiation oncology portfolio.

MedAssets is one of the largest group purchasing organizations in the U.S., utilizing a national contract portfolio of over 1,500 contracts to efficiently connect manufacturers, distributors and other suppliers with its more than 1,700 hospitals and over 40,000 non-acute healthcare provider customers.

Ralph Vaello, TomoTherapy's chief commercial officer, said, "MedAssets is a well-respected organization with expertise in supply chain consulting. We are honored to partner with them, and confident our collaboration with MedAssets will open doors to new institutions seeking an innovative radiation oncology solution."

About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy^® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions include its flagship Hi·Art^® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD^™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile^™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

(C)2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.